- Resources for Journalists
Doctors continue prescribing anti-anxiety medications such as lorazepam or diazepam for long periods despite the risk of addictions. Meanwhile, under-investment in psychological care is making things worse.
In many European countries, the availability of psychological treatment in the public healthcare system is inadequate or even non-existent. Barriers such as long waiting lists, co-payments and inadequate resources push people with anxiety or depression – those who can afford it – to the private system.
Mental health resources in the European Union were scarce even before the pandemic. COVID-19 has caused a tsunami in mental health, and access to care is more difficult today. About 75 percent of psychiatry services in the EU have been taking place via telemedicine, but this is not a viable option for all patients.
Pharmaceutical giants producing COVID-19 vaccines are open to collaboration with third parties, as long as they retain control on vaccine licenses and profits. EU member states complain about supply shortages, but fail to question the power of Big Pharma.
The European Union shifts between defending citizens’ health and defending pharmaceutical industry monopoly by opposing the liberalization of vaccine production. This might only delay achieving the immunisation necessary for economic recovery. We delve into this issue in a three-part investigation.
The Rapid Alert System for Food and Feed (RASFF) has been put in place by the European Commission to provide food and feed control authorities with an effective tool to exchange information about measures taken responding to serious risks detected in relation to food or feed.
The Covid-19 pandemic is a cruel reminder that ecosystem vitality and human health are closely linked. For Eloi Laurent, "the best economic policy is a good health policy and the best health policy is a good environmental policy. We see that there is no trade-off between economy and environment."
Compared to the first wave in spring, excess deaths this autumn are less concentrated in a few hard-hit regions. As Europe’s second wave begins to pass its peak, we’ve gathered data from over 750 regions in Europe so as to track the real toll of the pandemic.
Slow starts, supply shortages, disorganised and ad hoc management… Responses to COVID-19 across Europe have hardly been an occasion for pride. The OECD stresses the need to take into account the social inequalities in health, and consider health an investment rather than an expense.
Since the beginning of the pandemic, Italian authorities have allocated almost five billion euro for the supply of materials necessary for containing the spread of the virus. 1.7 billion went to foreign companies. An analysis of the public contracts awarded in response to Covid-19 in Italy.